Cargando…

Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment

Background: In polymyalgia rheumatica (PMR), data on bone turnover markers (BTM), on Wnt inhibitors (Dkk-1, sclerostin) and their changes induced by glucocorticoids (GC) are lacking. The aims of our study were to compare the baseline levels of Wnt inhibitors and BTM in PMR patients with healthy cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fassio, Angelo, Adami, Giovanni, Idolazzi, Luca, Giollo, Alessandro, Viapiana, Ombretta, Vantaggiato, Elisabetta, Benini, Camilla, Rossini, Maurizio, Dejaco, Christian, Gatti, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509037/ https://www.ncbi.nlm.nih.gov/pubmed/33015101 http://dx.doi.org/10.3389/fmed.2020.00551

Ejemplares similares

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Giovanni, Orsolini, et al.
Publicado: (2018)

Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?
por: Adami, Giovanni, et al.
Publicado: (2021)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Gender disparity in authorship of guidelines and recommendations in rheumatology
por: Adami, Giovanni, et al.
Publicado: (2020)

Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides
por: Adami, Giovanni, et al.
Publicado: (2021)

Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
por: Adami, Giovanni, et al.
Publicado: (2023)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
por: Cioffi, Giovanni, et al.
Publicado: (2021)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
por: Bertoldo, Eugenia, et al.
Publicado: (2021)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
por: Adami, Giovanni, et al.
Publicado: (2022)

Acute Phase Reaction and Fracture Risk Reduction: Are Gamma‐Delta T Cells and Hypovitaminosis D the Missing Link?
por: Adami, Giovanni, et al.
Publicado: (2022)

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2021)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
por: Rotta, Denise, et al.
Publicado: (2020)

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Clinical development of neridronate: potential for new applications
por: Gatti, Davide, et al.
Publicado: (2013)

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2020)

Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Polymyalgia Rheumatica
por: Dixon, A. St J.
Publicado: (1969)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Changes in bone turnover markers and bone modulators during abatacept treatment
por: Adami, Giovanni, et al.
Publicado: (2023)

Methoden zur Erfassung der Krankheitsaktivität der Polymyalgia rheumatica
por: Reisch, Myriam, et al.
Publicado: (2023)

Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
por: Mori, Shunsuke, et al.
Publicado: (2014)

An update on polymyalgia rheumatica
por: Lundberg, Ingrid E., et al.
Publicado: (2022)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Withdrawal of Glucocorticoid Therapy is Difficult in Women with Polymyalgia Rheumatica: An Observational Study
por: Aoki, Dai, et al.
Publicado: (2021)

Polymyalgia rheumatica: an autoinflammatory disorder?
por: Floris, Alberto, et al.
Publicado: (2018)

Polymyalgia rheumatica: An update (Review)
por: Florescu, Mirela Marinela, et al.
Publicado: (2023)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
por: Bixio, Riccardo, et al.
Publicado: (2022)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
por: Fassio, Angelo, et al.
Publicado: (2022)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Peripheral arterial disease in polymyalgia rheumatica
por: Borg, Frances A, et al.
Publicado: (2009)

Polymyalgia rheumatica in a married couple
por: Rüst, Christoph Alexander, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bl7rltnncup9hts82sivpifdpt